Release-controlling absorption enhancement of enterally administered Ophiopogon Japonicus polysaccharide by sodium caprate in rats

Journal of Pharmaceutical Sciences

Volumn 95, Issue 11, 2006, Pages 2534-2542

  Lin, Xiao ^a   Xu, De Sheng ^a   Feng, Yi ^a   Li, Song Ming ^a   Lu, Zhi Ling ^a   Shen, Lan ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Controlled release; Intestinal absorption enhancement; Polysaccharide; Sodium alginate; Sodium caprate

Indexed keywords

ALGINIC ACID; DECANOATE SODIUM; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; OPHIOPOGON ROOT; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DILUTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG FORMULATION; DRUG RELEASE; INTESTINE ABSORPTION; INTESTINE FLUID; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MEDICINAL PLANT; MOLECULAR WEIGHT; NONHUMAN; RAT; TABLET FORMULATION;

EID: 33750901117     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20738     Document Type: Article

References (14)

1. Xu DS, Feng Y, Lin X, Deng HL, Fang JN, Dong Q. 2005. Isolation, purification and structural analysis of a polysaccharide MDG-1 from Ophiopogon Japonicus. Acta Pharmaceutica Sinica 40:636-639.
2. Xu DS, Feng Y, Zhou YH, Zhang XC, Lin X, Deng HL. 2004. Active components of polysaccharide of Ophiopogon Japonicus on acute myocardial ischemia. Chin Tradit Patent Med 26:832-837.
3. Lin X, Xu DS, Feng Y. 2003. Research progress on intestinal absorption enhancers for macromolecular drugs. Chin Pharm J 38:741-744.
4. Hayashi M, Sakai T, Hasegawa Y, Nishikawahara T, Tomioka H, Iida A, Shimizu N, Tomita M, Awazu S. 1999. Physiological mechanism for enhancement of paracellular drug transport. J Control Rel 62: 141-148.
5. Anderberg EK, Lindmark T, Artursson P. 1993. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm Res 10:857-864.
6. Baluom M, Friedman M, Rubinstein A. 1998. The importance of intestinal residence time of absorption enhancer on drug absorption and implication on formulative considerations. Int J Pharm 176: 21-30.
7. Shameem M, Katori N, Aoyagi N, Kojima S. 1995. Oral solid controlled release dosage forms: Role of GI-mechanical destructive forces and colonic release in drug absorption under fasted and fed conditions in humans. Pharm Res 12:1049-1054.
8. Phillips SF. 1973. Integration of secretory and absorptive function. Mayo Clin Proc 48:630-633.
9. de Belder AN, Granath K. 1973. Preparation and properties of fluorescein-labelled dextrans. Carbohydr Res 30:375-378.
10. Lin X, Xu DS, Feng Y, Shen L. 2005. Determination of Ophiopogon Japonicus polysaccharide in plasma by HPLC with modified postcolumn fluorescence derivatization. Anal Biochem 342:179-185.
11. Lin X, Chen JM. 2002. Several approaches to prepare matrices containing soluble drug with zero-order release kinetics. Chin Pharm J 37: 192-195.
12. Gombotz WR, Wee SF. 1998. Protein release from alginate matrices. Adv Drug Deliv Rev 31:267-285.
13. Hochman J, Artursson P. 1994. Mechanism of absorption enhancement and tight junction regulation, J Control Rel 29:253-267.
14. Baluom M, Friedman M, Assaf P, Haj-Yehia AI, Rubinstein A. 2000. Synchronized release of sulpiride and sodium decanoate from HPMC matrices: A rational approach to enhance sulpiride absorption in the rat intestine. Pharm Res 17:1071-1076.